To scan or not to scan: DaT is the question

TY - JOUR

T1 - To scan or not to scan

T2 - DaT is the question

AU - Perlmutter, Joel S.

AU - Eidelberg, David

N1 - Funding Information: Study funding: J.S.P. was supported by NIH/NINDS grants NS05042, NS41509, NS058714, P30NS057105 (the Neuroscience Blueprint Core Grant to Washington University) , UL RR024992 (CTSA at Washington University), the Greater St. Louis Chapter of the American Parkinson Disease Association (APDA), the APDA Advanced Center for PD Research at Washington University, and the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund and the PD Research Fund). D.E. was supported by the NIH/NINDS Morris K. Udall Center of Excellence for Parkinson's Disease (P50 NS071675) at the Feinstein Institute for Medical Research. Funding Information: Dr. Perlmutter serves on scientific advisory boards for American Parkinson Disease Association, Dystonia Medical Research Foundation, Missouri Chapter of the Dystonia Medical Research Fund, Greater St. Louis Chapter of the APDA; serves on the editorial board of Neurology®; has received honoraria for grant reviews from the Parkinson Disease Study Group; receives research support from Express Scripts, the NIH, the Huntington Disease Society of American Center of Excellence, the Michael J Fox Foundation, CHDI (formerly HiQ Foundation), McDonnell Center for Higher Brain Function: Greater St. Louis Chapter of the American Parkinson Disease Association, American Parkinson Disease Association, APDA Advanced PD Research Center at Washington University, and BJH Foundation; and has provided expert testimony in a medico-legal case. Dr. Eidelberg serves on scientific advisory boards for and has received honoraria from the Thomas Hartman Foundation for Parkinson's Research, Inc., the Michael J. Fox Foundation, and the Bachmann-Strauss Dystonia and Parkinson Foundation; has served as a consultant for Neurologix, Inc. and Merck & Co., Inc.; serves on the editorial board of Annals of Neurology and as Associate Editor for the Journal of Neuroscience; is listed as coinventor of patents re: Markers for use in screening patients for nervous system dysfunction and a method and apparatus for using same; has received research support from the NIH (NINDS, NCRR, NIDCD, NIAID), High Q Foundation, the Dana Foundation, and the Bachmann-Strauss Dystonia and Parkinson Foundation; and has served as an expert in medico-legal cases.

PY - 2012/3/6

Y1 - 2012/3/6

UR - http://www.scopus.com/inward/record.url?scp=84860829158&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3182494c72

DO - 10.1212/WNL.0b013e3182494c72

M3 - Editorial

C2 - 22323757

AN - SCOPUS:84860829158

SN - 0028-3878

VL - 78

SP - 688

EP - 689

JO - Neurology

JF - Neurology

IS - 10

ER -